We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use iwcll.org, remember your settings and improve our services. We also use cookies set by other sites to help us deliver content from their services.
Moritz Furstenau, Long-term efficacy and safety of maintenance with lenalidomide in patients with chronic lymphocytic leukaemia and a high risk of progression after first-line immunochemotherapy
Home > Resources > Moritz Furstenau, Long-term efficacy and safety of maintenance with lenalidomide in patients with chronic lymphocytic leukaemia and a high risk of progression after first-line immunochemotherapy
